Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bar-Hai N"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasis.
Autor:
Israeli Dangoor S; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Khoury R; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Salomon K; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Pozzi S; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Shahar S; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Miari A; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Leichtmann-Bardoogo Y; Department of Biomedical Engineering, Tel Aviv University, Tel Aviv, 6997801, Israel., Bar-Hai N; Cancer Research Center, Oncology Institute, Sheba Medical Center, Tel-Hashomer, 5262000, Israel.; Affiliated with Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Frommer N; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Yeini E; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Winkler T; Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Balint Lahat N; Department of Pathology, Sheba Medical Center, Tel Hashomer, 5262000, Israel., Kamer I; Cancer Research Center, Oncology Institute, Sheba Medical Center, Tel-Hashomer, 5262000, Israel., Hadad O; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Laue K; Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Brem H; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA., Hyde TM; Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21218, USA.; Department of Psychiatry & Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA.; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA., Bar J; Cancer Research Center, Oncology Institute, Sheba Medical Center, Tel-Hashomer, 5262000, Israel., Barshack I; Department of Pathology, Sheba Medical Center, Tel Hashomer, 5262000, Israel.; Department of Pathology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Ben-David U; Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Ishay-Ronen D; Cancer Research Center, Oncology Institute, Sheba Medical Center, Tel-Hashomer, 5262000, Israel.; Affiliated with Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel., Maoz BM; Department of Biomedical Engineering, Tel Aviv University, Tel Aviv, 6997801, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 6997801, Israel.; Sagol Center for Regenerative Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel.; The Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, 6997801, Israel., Satchi-Fainaro R; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 6997801, Israel.; The Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, 6997801, Israel.
Publikováno v:
Brain : a journal of neurology [Brain] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.
Autor:
Bar-Hai N; Oncology Institute, Shaba Medical Center, Ramat-Gan, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Ben-Yishay R; Oncology Institute, Shaba Medical Center, Ramat-Gan, Israel., Arbili-Yarhi S; Oncology Institute, Shaba Medical Center, Ramat-Gan, Israel., Herman N; Department of General Surgery, Shaba Medical Center, Ramat-Gan, Israel., Avidan-Noy V; Department of General Surgery, Shaba Medical Center, Ramat-Gan, Israel., Menes T; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of General Surgery, Shaba Medical Center, Ramat-Gan, Israel., Mansour A; Department of General Surgery, Shaba Medical Center, Ramat-Gan, Israel., Awwad F; Department of General Surgery, Shaba Medical Center, Ramat-Gan, Israel., Balint-Lahat N; Institute of Pathology, Shaba Medical Center, Ramat-Gan, Israel., Goldinger G; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Institute of Pathology, Shaba Medical Center, Ramat-Gan, Israel., Hout-Siloni G; Institute of Pathology, Shaba Medical Center, Ramat-Gan, Israel., Adileh M; Department of Surgery, Mount Scopus, Hadassah Hebrew University Medical Center, Jerusalem, Israel., Berger R; Oncology Institute, Shaba Medical Center, Ramat-Gan, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Ishay-Ronen D; Oncology Institute, Shaba Medical Center, Ramat-Gan, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Oct 14; Vol. 14, pp. 1470379. Date of Electronic Publication: 2024 Oct 14 (Print Publication: 2024).